ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jun 06, 2019 11:00 JST
Source:
AcroMeta Group Limited
ACROMEC Signs LOI for Collaboration to Own-Operate Private Fertility Centre
- Two renowned medical specialists as core management team
- Leading US fertility centre to be strategic investor and adviser
- ACROMEC to acquire the premises and equipment for the fertility centre
SINGAPORE, Jun 06, 2019 - (ACN Newswire) - ACROMEC Limited ("ACROMEC", or the "Company" and together with its subsidiary, the "Group"), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, today announced that the Company has entered into a letter of intent ("LOI") for a proposed collaboration to own and operate a private fertility center. The LOI sets out the principal terms of the proposed collaboration.
The LOI is entered into with two renowned specialists in the field of fertility medicine who will lead the core management team, and with a leading US fertility centre as strategic investor and adviser.
The assets required for the operation of the centre, such as the premises and equipment are intended to be acquired by ACROMEC from a former customer of the Group which has now been placed under judicial management.
The Board believes that the proposed collaboration presents a strategic opportunity for the Group to raise its core engineering services business to the next higher value-add level. The Group is working towards a turn-key model where it can source for the funding, design, build, and outfit of medical facilities, to lease out or self-operate upon completion.
Commenting on the LOI, Mr Lim Say Chin, Executive Chairman and Managing Director of ACROMEC, said, "This proposed collaboration is an opportunity to participate in the growth of the fertility business in the region. The high economic growth of the countries in the region, as well changes in demographics and developments in procreation sciences has spawned a strong demand for medical fertility services."
About ACROMEC Limited (SGX Stock Code: 1CH1)
ACROMEC is an established specialist engineering services provider with more than 20 years of experience in the field of controlled environments. The Group has over the years acquired expertise in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms.
ACROMEC's business is divided into two main business segments: (i) Engineering, procurement and construction services, specialising in architectural, and mechanical, electrical and process works within controlled environments; and (ii) Maintenance and repair services of facilities and equipment of controlled environments and their supporting infrastructure.
The Group mainly serves the healthcare, pharmaceutical, biomedical science, research and academia, and electronics sectors. ACROMEC counts amongst its customers, hospitals and medical centres, government agencies, research and development companies or agencies, research and development units of multinational corporations, tertiary educational institutions, pharmaceutical companies, semiconductor manufacturing companies, and multinational engineering companies. For more information, please visit www.ACROMEC.com.
Media and Analysts Contact:
ACROMEC Limited
Mr Jerry Tan
Chief Financial Officer
Tel: +65 6415 0574
Email:
jerry.tan@ACROMEC.com
Waterbrooks Consultant Pte Ltd
Ng Tian Khean
Mobile: +65 96402808
Email:
tk@waterbrooks.com.sg
Source: AcroMeta Group Limited
Sectors: Healthcare & Pharm, Construct, Engineering
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud
May 17, 2024 11:19 JST
Honda and IBM sign Memorandum of Understanding to Explore Long-term Joint Research and Development of Semiconductor Chip and Software Technologies for Future Software-Defined Vehicles
May 15, 2024 14:30 JST
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
May 15, 2024 11:19 JST
SMEIC Proposes to Acquire Shanghai Prime: A Catalyst for Developing a New Dual-Wheel Driver Pattern
May 14, 2024 21:54 JST
DENSO and Certhon Introduce Artemy, A Fully Automated Cherry Truss Tomato Harvesting Robot
May 14, 2024 11:02 JST
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
May 13, 2024 18:32 JST
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures
May 13, 2024 17:06 JST
Ogier and TOYOTA GAZOO Racing triumph again
May 13, 2024 14:36 JST
Spa points haul for TOYOTA GAZOO Racing
May 13, 2024 13:56 JST
DOCOMO to Launch NTT DOCOMO GLOBAL for Global Expansion
May 10, 2024 18:13 JST
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 10, 2024 12:20 JST
Paltalk, Inc. Reports Slight Increase in Revenue and 33% Reduction in Net Loss for First Quarter 2024
May 09, 2024 20:39 JST
Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
May 09, 2024 19:00 JST
Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 09, 2024 14:13 JST
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 09, 2024 10:41 JST
Mitsubishi Heavy Industries Increases Dividends on Back of Historically High FY2023 Results, Releases FY2024 Guidance
May 08, 2024 14:27 JST
Rome becomes the first European city to offer open loop transit payments to JCB Cardmembers
May 08, 2024 12:00 JST
NEC X Invests in Public Safety Startup Multitude Insights, Scaling AI-Powered Collaboration and Information Sharing for Law Enforcement
May 08, 2024 10:24 JST
ServiceNow and Fujitsu announce strategic commitment to launch innovative cross-industry solutions
May 08, 2024 08:52 JST
Fujitsu launches mainframe modernization automation service for the Japanese market
May 07, 2024 17:53 JST
More Latest Release >>
Related Release
AcroMeta Receives Buy-Out Offer for its Controlled Environments Engineering Subsidiary
January 26 2024 11:00 JST
Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China
December 12 2023 22:20 JST
Acrometa Posts Record Revenue of S$69.5 Million for FY2023, Continues to Pursue New Opportunities in Co-Working Lab Space Business
November 29 2023 20:00 JST
Acrometa Subsidiary Signs Two MOUs to Develop Co-Working Laboratory Space Business in China
November 17 2023 21:00 JST
Acrometa Group Signs MOU for Sand Concession, Opening New Business Opportunities in the Region
November 06 2023 21:00 JST
Acrometa to Focus on Laboratory Construction and Co-Working Laboratory Space Business
October 31 2023 21:00 JST
ACROMETA's Life Science Incubator (LSI) Signs Agreement with Ho Bee Land subsidiary to operate Co-Working Laboratory
October 06 2023 17:30 JST
AcroMeta's Laboratory Construction Business Rides on Singapore's Pandemic Readiness Strategy
August 15 2023 20:00 JST
Life Science Incubator Signs MOU with a strategic anchor tenant for its planned Brisbane Co-Working Laboratory Space Project
April 06 2023 14:00 JST
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
March 31 2023 20:15 JST
More Press release >>